カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の禁煙薬市場2022年：NRTs製品、ニコチンフリー製品

◆英語タイトル：Global Smoking Cessation Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22MY8963）◆商品コード：GIR22MY8963
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2022年5月（※2025年版があります。お問い合わせください。）
◆ページ数：107
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

禁煙薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の禁煙薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

禁煙薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・NRTs製品、ニコチンフリー製品

用途別セグメントは次のように区分されます。
・病院薬局、小売薬局、オンライン薬局、その他

世界の禁煙薬市場の主要な市場プレーヤーは以下のとおりです。
・GSK、Pfizer、Kimree Technology、Johnson & Johnson、Novartis、Dr. Reddy's Laboratories、The Harvard Drug Group、Perrigo Company、Fontem Ventures、Smoke Away

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、禁煙薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な禁煙薬メーカーの企業概要、2019年～2022年までの禁煙薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な禁煙薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別禁煙薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの禁煙薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での禁煙薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および禁煙薬の産業チェーンを掲載しています。
・第13、14、15章では、禁煙薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：GSK、Pfizer、Kimree Technology、Johnson & Johnson、Novartis、Dr. Reddy's Laboratories、The Harvard Drug Group、Perrigo Company、Fontem Ventures、Smoke Away
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：NRTs製品、ニコチンフリー製品
・用途別分析2017年-2028年：病院薬局、小売薬局、オンライン薬局、その他
・禁煙薬の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・禁煙薬のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・禁煙薬のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・禁煙薬の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・禁煙薬の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Smoking Cessation Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Smoking Cessation Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Smoking Cessation Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While NRTs Products segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Smoking Cessation Drugs include GSK, Pfizer, Kimree Technology, Johnson & Johnson, and Novartis, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Smoking Cessation Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
NRTs Products
Nicotine-Free Products
Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
The key market players for global Smoking Cessation Drugs market are listed below:
GSK
Pfizer
Kimree Technology
Johnson & Johnson
Novartis
Dr. Reddy’s Laboratories
The Harvard Drug Group
Perrigo Company
Fontem Ventures
Smoke Away
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Smoking Cessation Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Smoking Cessation Drugs, with price, sales, revenue and global market share of Smoking Cessation Drugs from 2019 to 2022.
Chapter 3, the Smoking Cessation Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Smoking Cessation Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Smoking Cessation Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Smoking Cessation Drugs.
Chapter 13, 14, and 15, to describe Smoking Cessation Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Smoking Cessation Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Smoking Cessation Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 NRTs Products
1.2.3 Nicotine-Free Products
1.3 Market Analysis by Application
1.3.1 Overview: Global Smoking Cessation Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Global Smoking Cessation Drugs Market Size & Forecast
1.4.1 Global Smoking Cessation Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Smoking Cessation Drugs Sales in Volume (2017-2028)
1.4.3 Global Smoking Cessation Drugs Price (2017-2028)
1.5 Global Smoking Cessation Drugs Production Capacity Analysis
1.5.1 Global Smoking Cessation Drugs Total Production Capacity (2017-2028)
1.5.2 Global Smoking Cessation Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Smoking Cessation Drugs Market Drivers
1.6.2 Smoking Cessation Drugs Market Restraints
1.6.3 Smoking Cessation Drugs Trends Analysis
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Smoking Cessation Drugs Product and Services
2.1.4 GSK Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Smoking Cessation Drugs Product and Services
2.2.4 Pfizer Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Kimree Technology
2.3.1 Kimree Technology Details
2.3.2 Kimree Technology Major Business
2.3.3 Kimree Technology Smoking Cessation Drugs Product and Services
2.3.4 Kimree Technology Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Smoking Cessation Drugs Product and Services
2.4.4 Johnson & Johnson Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Smoking Cessation Drugs Product and Services
2.5.4 Novartis Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Dr. Reddy’s Laboratories
2.6.1 Dr. Reddy’s Laboratories Details
2.6.2 Dr. Reddy’s Laboratories Major Business
2.6.3 Dr. Reddy’s Laboratories Smoking Cessation Drugs Product and Services
2.6.4 Dr. Reddy’s Laboratories Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 The Harvard Drug Group
2.7.1 The Harvard Drug Group Details
2.7.2 The Harvard Drug Group Major Business
2.7.3 The Harvard Drug Group Smoking Cessation Drugs Product and Services
2.7.4 The Harvard Drug Group Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Perrigo Company
2.8.1 Perrigo Company Details
2.8.2 Perrigo Company Major Business
2.8.3 Perrigo Company Smoking Cessation Drugs Product and Services
2.8.4 Perrigo Company Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Fontem Ventures
2.9.1 Fontem Ventures Details
2.9.2 Fontem Ventures Major Business
2.9.3 Fontem Ventures Smoking Cessation Drugs Product and Services
2.9.4 Fontem Ventures Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Smoke Away
2.10.1 Smoke Away Details
2.10.2 Smoke Away Major Business
2.10.3 Smoke Away Smoking Cessation Drugs Product and Services
2.10.4 Smoke Away Smoking Cessation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Smoking Cessation Drugs Breakdown Data by Manufacturer
3.1 Global Smoking Cessation Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Smoking Cessation Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Smoking Cessation Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Smoking Cessation Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Smoking Cessation Drugs Manufacturer Market Share in 2021
3.5 Global Smoking Cessation Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Smoking Cessation Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Smoking Cessation Drugs Market Size by Region
4.1.1 Global Smoking Cessation Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Smoking Cessation Drugs Revenue by Region (2017-2028)
4.2 North America Smoking Cessation Drugs Revenue (2017-2028)
4.3 Europe Smoking Cessation Drugs Revenue (2017-2028)
4.4 Asia-Pacific Smoking Cessation Drugs Revenue (2017-2028)
4.5 South America Smoking Cessation Drugs Revenue (2017-2028)
4.6 Middle East and Africa Smoking Cessation Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Smoking Cessation Drugs Sales in Volume by Type (2017-2028)
5.2 Global Smoking Cessation Drugs Revenue by Type (2017-2028)
5.3 Global Smoking Cessation Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Smoking Cessation Drugs Sales in Volume by Application (2017-2028)
6.2 Global Smoking Cessation Drugs Revenue by Application (2017-2028)
6.3 Global Smoking Cessation Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Smoking Cessation Drugs Sales by Type (2017-2028)
7.2 North America Smoking Cessation Drugs Sales by Application (2017-2028)
7.3 North America Smoking Cessation Drugs Market Size by Country
7.3.1 North America Smoking Cessation Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Smoking Cessation Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Smoking Cessation Drugs Sales by Type (2017-2028)
8.2 Europe Smoking Cessation Drugs Sales by Application (2017-2028)
8.3 Europe Smoking Cessation Drugs Market Size by Country
8.3.1 Europe Smoking Cessation Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Smoking Cessation Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Smoking Cessation Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Smoking Cessation Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Smoking Cessation Drugs Market Size by Region
9.3.1 Asia-Pacific Smoking Cessation Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Smoking Cessation Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Smoking Cessation Drugs Sales by Type (2017-2028)
10.2 South America Smoking Cessation Drugs Sales by Application (2017-2028)
10.3 South America Smoking Cessation Drugs Market Size by Country
10.3.1 South America Smoking Cessation Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Smoking Cessation Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Smoking Cessation Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Smoking Cessation Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Smoking Cessation Drugs Market Size by Country
11.3.1 Middle East & Africa Smoking Cessation Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Smoking Cessation Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Smoking Cessation Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Smoking Cessation Drugs
12.3 Smoking Cessation Drugs Production Process
12.4 Smoking Cessation Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Smoking Cessation Drugs Typical Distributors
13.3 Smoking Cessation Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Smoking Cessation Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Smoking Cessation Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Smoking Cessation Drugs Product and Services
Table 6. GSK Smoking Cessation Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Smoking Cessation Drugs Product and Services
Table 10. Pfizer Smoking Cessation Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Kimree Technology Basic Information, Manufacturing Base and Competitors
Table 12. Kimree Technology Major Business
Table 13. Kimree Technology Smoking Cessation Drugs Product and Services
Table 14. Kimree Technology Smoking Cessation Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson Smoking Cessation Drugs Product and Services
Table 18. Johnson & Johnson Smoking Cessation Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Novartis Basic Information, Manufacturing Base and Competitors
Table 20. Novartis Major Business
Table 21. Novartis Smoking Cessation Drugs Product and Services
Table 22. Novartis Smoking Cessation Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 24. Dr. Reddy's Laboratories Major Business
Table 25. Dr. Reddy's Laboratories Smoking Cessation Drugs Product and Services
Table 26. Dr. Reddy's Laboratories Smoking Cessation Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. The Harvard Drug Group Basic Information, Manufacturing Base and Competitors
Table 28. The Harvard Drug Group Major Business
Table 29. The Harvard Drug Group Smoking Cessation Drugs Product and Services
Table 30. The Harvard Drug Group Smoking Cessation Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Perrigo Company Basic Information, Manufacturing Base and Competitors
Table 32. Perrigo Company Major Business
Table 33. Perrigo Company Smoking Cessation Drugs Product and Services
Table 34. Perrigo Company Smoking Cessation Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Fontem Ventures Basic Information, Manufacturing Base and Competitors
Table 36. Fontem Ventures Major Business
Table 37. Fontem Ventures Smoking Cessation Drugs Product and Services
Table 38. Fontem Ventures Smoking Cessation Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Smoke Away Basic Information, Manufacturing Base and Competitors
Table 40. Smoke Away Major Business
Table 41. Smoke Away Smoking Cessation Drugs Product and Services
Table 42. Smoke Away Smoking Cessation Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Smoking Cessation Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K MT)
Table 44. Global Smoking Cessation Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Smoking Cessation Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Smoking Cessation Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 47. Head Office and Smoking Cessation Drugs Production Site of Key Manufacturer
Table 48. Smoking Cessation Drugs New Entrant and Capacity Expansion Plans
Table 49. Smoking Cessation Drugs Mergers & Acquisitions in the Past Five Years
Table 50. Global Smoking Cessation Drugs Sales by Region (2017-2022) & (K MT)
Table 51. Global Smoking Cessation Drugs Sales by Region (2023-2028) & (K MT)
Table 52. Global Smoking Cessation Drugs Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Smoking Cessation Drugs Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Smoking Cessation Drugs Sales by Type (2017-2022) & (K MT)
Table 55. Global Smoking Cessation Drugs Sales by Type (2023-2028) & (K MT)
Table 56. Global Smoking Cessation Drugs Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Smoking Cessation Drugs Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Smoking Cessation Drugs Price by Type (2017-2022) & (USD/MT)
Table 59. Global Smoking Cessation Drugs Price by Type (2023-2028) & (USD/MT)
Table 60. Global Smoking Cessation Drugs Sales by Application (2017-2022) & (K MT)
Table 61. Global Smoking Cessation Drugs Sales by Application (2023-2028) & (K MT)
Table 62. Global Smoking Cessation Drugs Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Smoking Cessation Drugs Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Smoking Cessation Drugs Price by Application (2017-2022) & (USD/MT)
Table 65. Global Smoking Cessation Drugs Price by Application (2023-2028) & (USD/MT)
Table 66. North America Smoking Cessation Drugs Sales by Country (2017-2022) & (K MT)
Table 67. North America Smoking Cessation Drugs Sales by Country (2023-2028) & (K MT)
Table 68. North America Smoking Cessation Drugs Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Smoking Cessation Drugs Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Smoking Cessation Drugs Sales by Type (2017-2022) & (K MT)
Table 71. North America Smoking Cessation Drugs Sales by Type (2023-2028) & (K MT)
Table 72. North America Smoking Cessation Drugs Sales by Application (2017-2022) & (K MT)
Table 73. North America Smoking Cessation Drugs Sales by Application (2023-2028) & (K MT)
Table 74. Europe Smoking Cessation Drugs Sales by Country (2017-2022) & (K MT)
Table 75. Europe Smoking Cessation Drugs Sales by Country (2023-2028) & (K MT)
Table 76. Europe Smoking Cessation Drugs Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Smoking Cessation Drugs Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Smoking Cessation Drugs Sales by Type (2017-2022) & (K MT)
Table 79. Europe Smoking Cessation Drugs Sales by Type (2023-2028) & (K MT)
Table 80. Europe Smoking Cessation Drugs Sales by Application (2017-2022) & (K MT)
Table 81. Europe Smoking Cessation Drugs Sales by Application (2023-2028) & (K MT)
Table 82. Asia-Pacific Smoking Cessation Drugs Sales by Region (2017-2022) & (K MT)
Table 83. Asia-Pacific Smoking Cessation Drugs Sales by Region (2023-2028) & (K MT)
Table 84. Asia-Pacific Smoking Cessation Drugs Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Smoking Cessation Drugs Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Smoking Cessation Drugs Sales by Type (2017-2022) & (K MT)
Table 87. Asia-Pacific Smoking Cessation Drugs Sales by Type (2023-2028) & (K MT)
Table 88. Asia-Pacific Smoking Cessation Drugs Sales by Application (2017-2022) & (K MT)
Table 89. Asia-Pacific Smoking Cessation Drugs Sales by Application (2023-2028) & (K MT)
Table 90. South America Smoking Cessation Drugs Sales by Country (2017-2022) & (K MT)
Table 91. South America Smoking Cessation Drugs Sales by Country (2023-2028) & (K MT)
Table 92. South America Smoking Cessation Drugs Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Smoking Cessation Drugs Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Smoking Cessation Drugs Sales by Type (2017-2022) & (K MT)
Table 95. South America Smoking Cessation Drugs Sales by Type (2023-2028) & (K MT)
Table 96. South America Smoking Cessation Drugs Sales by Application (2017-2022) & (K MT)
Table 97. South America Smoking Cessation Drugs Sales by Application (2023-2028) & (K MT)
Table 98. Middle East & Africa Smoking Cessation Drugs Sales by Region (2017-2022) & (K MT)
Table 99. Middle East & Africa Smoking Cessation Drugs Sales by Region (2023-2028) & (K MT)
Table 100. Middle East & Africa Smoking Cessation Drugs Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Smoking Cessation Drugs Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Smoking Cessation Drugs Sales by Type (2017-2022) & (K MT)
Table 103. Middle East & Africa Smoking Cessation Drugs Sales by Type (2023-2028) & (K MT)
Table 104. Middle East & Africa Smoking Cessation Drugs Sales by Application (2017-2022) & (K MT)
Table 105. Middle East & Africa Smoking Cessation Drugs Sales by Application (2023-2028) & (K MT)
Table 106. Smoking Cessation Drugs Raw Material
Table 107. Key Manufacturers of Smoking Cessation Drugs Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Smoking Cessation Drugs Typical Distributors
Table 111. Smoking Cessation Drugs Typical Customers
List of Figures
Figure 1. Smoking Cessation Drugs Picture
Figure 2. Global Smoking Cessation Drugs Revenue Market Share by Type in 2021
Figure 3. NRTs Products
Figure 4. Nicotine-Free Products
Figure 5. Global Smoking Cessation Drugs Revenue Market Share by Application in 2021
Figure 6. Hospital Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Online Pharmacies
Figure 9. Others
Figure 10. Global Smoking Cessation Drugs Revenue, (USD Million) & (K MT): 2017 & 2021 & 2028
Figure 11. Global Smoking Cessation Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Smoking Cessation Drugs Sales (2017-2028) & (K MT)
Figure 13. Global Smoking Cessation Drugs Price (2017-2028) & (USD/MT)
Figure 14. Global Smoking Cessation Drugs Production Capacity (2017-2028) & (K MT)
Figure 15. Global Smoking Cessation Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Smoking Cessation Drugs Market Drivers
Figure 17. Smoking Cessation Drugs Market Restraints
Figure 18. Smoking Cessation Drugs Market Trends
Figure 19. Global Smoking Cessation Drugs Sales Market Share by Manufacturer in 2021
Figure 20. Global Smoking Cessation Drugs Revenue Market Share by Manufacturer in 2021
Figure 21. Smoking Cessation Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Smoking Cessation Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Smoking Cessation Drugs Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Smoking Cessation Drugs Sales Market Share by Region (2017-2028)
Figure 25. Global Smoking Cessation Drugs Revenue Market Share by Region (2017-2028)
Figure 26. North America Smoking Cessation Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Europe Smoking Cessation Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Smoking Cessation Drugs Revenue (2017-2028) & (USD Million)
Figure 29. South America Smoking Cessation Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Smoking Cessation Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Global Smoking Cessation Drugs Sales Market Share by Type (2017-2028)
Figure 32. Global Smoking Cessation Drugs Revenue Market Share by Type (2017-2028)
Figure 33. Global Smoking Cessation Drugs Price by Type (2017-2028) & (USD/MT)
Figure 34. Global Smoking Cessation Drugs Sales Market Share by Application (2017-2028)
Figure 35. Global Smoking Cessation Drugs Revenue Market Share by Application (2017-2028)
Figure 36. Global Smoking Cessation Drugs Price by Application (2017-2028) & (USD/MT)
Figure 37. North America Smoking Cessation Drugs Sales Market Share by Type (2017-2028)
Figure 38. North America Smoking Cessation Drugs Sales Market Share by Application (2017-2028)
Figure 39. North America Smoking Cessation Drugs Sales Market Share by Country (2017-2028)
Figure 40. North America Smoking Cessation Drugs Revenue Market Share by Country (2017-2028)
Figure 41. United States Smoking Cessation Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Smoking Cessation Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Smoking Cessation Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Smoking Cessation Drugs Sales Market Share by Type (2017-2028)
Figure 45. Europe Smoking Cessation Drugs Sales Market Share by Application (2017-2028)
Figure 46. Europe Smoking Cessation Drugs Sales Market Share by Country (2017-2028)
Figure 47. Europe Smoking Cessation Drugs Revenue Market Share by Country (2017-2028)
Figure 48. Germany Smoking Cessation Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Smoking Cessation Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Smoking Cessation Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Smoking Cessation Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Smoking Cessation Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Smoking Cessation Drugs Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Smoking Cessation Drugs Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Smoking Cessation Drugs Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Smoking Cessation Drugs Revenue Market Share by Region (2017-2028)
Figure 57. China Smoking Cessation Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Smoking Cessation Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Smoking Cessation Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Smoking Cessation Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Smoking Cessation Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Smoking Cessation Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Smoking Cessation Drugs Sales Market Share by Type (2017-2028)
Figure 64. South America Smoking Cessation Drugs Sales Market Share by Application (2017-2028)
Figure 65. South America Smoking Cessation Drugs Sales Market Share by Country (2017-2028)
Figure 66. South America Smoking Cessation Drugs Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Smoking Cessation Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Smoking Cessation Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Smoking Cessation Drugs Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Smoking Cessation Drugs Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Smoking Cessation Drugs Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Smoking Cessation Drugs Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Smoking Cessation Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Smoking Cessation Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Smoking Cessation Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Smoking Cessation Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Smoking Cessation Drugs in 2021
Figure 78. Manufacturing Process Analysis of Smoking Cessation Drugs
Figure 79. Smoking Cessation Drugs Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の禁煙薬市場2022年：NRTs製品、ニコチンフリー製品(Global Smoking Cessation Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 禁煙用ニコチン代替療法のグローバル市場展望 2023年-2029年：スプレー＆吸入器、ガム、パッチ、トローチ
  • 世界のニコチン禁煙市場インサイト及び予測（チューインガム、パッチ、スプレー＆吸入器、その他）
  • 世界の先端巨大症・巨人症治療薬市場2022年：ソマトスタチン類似体、GH受容体拮抗薬、ドーパミン作動薬、組換えヒトIGF-1
  • 世界の公共喫煙ブース市場2022年：1〜2人収容、2〜5人収容、5人以上収容
  • 世界の抗菌医薬品市場2022年：セファロスポリン系、ペニシリン系、フルオロキノロン系、マクロライド系、カルバペネム系、その他